BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Send T, Kreppel B, Gaertner FC, Bundschuh RA, Strunk H, Bootz F, Essler M. [PET-CT in head and neck cancer]. HNO 2017;65:504-13. [PMID: 28451717 DOI: 10.1007/s00106-017-0355-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Eilsberger F, Noltenius FE, Librizzi D, Wessendorf J, Luster M, Hoch S, Pfestroff A. Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor. Biomedicines 2022;10:2095. [DOI: 10.3390/biomedicines10092095] [Reference Citation Analysis]
2 Liu X, Wang SC, Ni M, Xie Q, Zhang YF, Lv WF, Geng GY. Correlation between 18F-FDG PET/CT intra-tumor metabolic heterogeneity parameters and KRAS mutation in colorectal cancer. Abdom Radiol (NY) 2022;47:1255-64. [PMID: 35138462 DOI: 10.1007/s00261-022-03432-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yaremenko SA, Rucheva NA, Sinitsin VE. The role of PET-CT with <sup>18</sup>F-FDG in initial assessment of patients with carcinoma of unknown primary (CUP) in the head and neck. Medicinskaâ vizualizaciâ 2022. [DOI: 10.24835/1607-0763-1087] [Reference Citation Analysis]
4 Yaremenko SA, Ruchyeva NA, Sinitsyn VE. Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary. Vestn rentgenol radiol 2021;102:208-216. [DOI: 10.20862/0042-4676-2021-102-4-208-216] [Reference Citation Analysis]